To install click the Add extension button. That's it.

The source code for the WIKI 2 extension is being checked by specialists of the Mozilla Foundation, Google, and Apple. You could also do it yourself at any point in time.

How to transfigure the Wikipedia

Would you like Wikipedia to always look as professional and up-to-date? We have created a browser extension. It will enhance any encyclopedic page you visit with the magic of the WIKI 2 technology.

Try it — you can delete it anytime.

Install in 5 seconds
4,5
Kelly Slayton
Congratulations on this excellent venture… what a great idea!
Alexander Grigorievskiy
I use WIKI 2 every day and almost forgot how the original Wikipedia looks like.
Live Statistics
English Articles
Improved in 24 Hours
Added in 24 Hours
What we do. Every page goes through several hundred of perfecting techniques; in live mode. Quite the same Wikipedia. Just better.
Great Wikipedia has got greater.
.
Leo
Newton
Brights
Milds

Sylvie Garneau-Tsodikova

From Wikipedia, the free encyclopedia

Sylvie Garneau-Tsodikova
Alma materUniversité Laval
University of Alberta
Scientific career
InstitutionsHarvard Medical School
University of Michigan
University of Kentucky
ThesisNew antimicrobial agents acting on bacterial cell walls. (2003)

Sylvie Garneau-Tsodikova is a French Canadian chemist who is a Professor and Associate Vice President for Research at the University of Kentucky. Her research considers the development of new molecules that can combat bacterial resistance.

Early life and education

Garneau-Tsodikova was born in Quebec City, Canada. She attended the Université Laval for her undergraduate studies in chemistry, where she graduated top of the class.[1] As a student, she was honoured with several awards, including distinguishments from the Chemical Institute of Canada and Natural Sciences and Engineering Research Council.[1] She completed a Master's thesis on the synthesis of glutamyl transfer RNA synthetase inhibitors.[2] She moved to the University of Alberta for graduate studies, where she worked on the impact of antimicrobial agents of bacterial cell walls.[3][4] During her doctoral studies she became interested in infectious diseases and the development of antibacterial agents.[5]

Research and career

Garneau-Tsodikova moved to the Harvard Medical School for her postdoctoral training where she worked with Christopher T. Walsh on the formation and modification of dipyrroles. At Harvard she was trained in both enzymology and biochemistry. In 2006, Garneau-Tsodikova moved to the University of Michigan, where she was made Assistant Professor in the College of Pharmacy.[6] She spent seven years at Michigan, until she moved to the University of Kentucky. She was promoted to Professor and Assistant Dean in 2018.[7]

Garneau-Tsodikova's research focuses on the development of antifungal and antibacterial agents.[5] In particular, Garneau-Tsodikova studied tuberculosis and Candida auris resistant pathogens.[5] She was involved with the development of multifunctional enzymes with tuneable biological properties. She is an Associate Editor of the Royal Society of Chemistry journal Medicinal Chemistry.[8]

Selected publications

  • Christopher T Walsh; Sylvie Garneau-Tsodikova; Gregory J Gatto (1 December 2005). "Protein posttranslational modifications: the chemistry of proteome diversifications". Angewandte Chemie International Edition. 44 (45): 7342–7372. doi:10.1002/ANIE.200501023. ISSN 1433-7851. PMID 16267872. Wikidata Q34465021.
  • Frédéric H Vaillancourt; Ellen Yeh; David A Vosburg; Sylvie Garneau-Tsodikova; Christopher T Walsh (1 August 2006). "Nature's inventory of halogenation catalysts: oxidative strategies predominate". Chemical Reviews. 106 (8): 3364–3378. doi:10.1021/CR050313I. ISSN 0009-2665. PMID 16895332. Wikidata Q34555225.
  • Sylvie Garneau; Nathaniel I Martin; John C Vederas (1 May 2002). "Two-peptide bacteriocins produced by lactic acid bacteria". Biochimie. 84 (5–6): 577–592. doi:10.1016/S0300-9084(02)01414-1. ISSN 0300-9084. PMID 12423802. Wikidata Q34992720.

References

  1. ^ a b "Sylvie Garneau-Tsodikova". UK College of Pharmacy. Retrieved 2021-04-17.
  2. ^ Garneau, Sylvie (1998). Synthèse d'inhibiteurs de la glutamyl t-ARN synthétase et approche à la synthèse du striatène (Thesis) (in French). Ottawa: National Library of Canada = Bibliothèque nationale du Canada. OCLC 46552296.
  3. ^ Garneau, Sylvie (2004). New antimicrobial agents acting on bacterial cell walls (Thesis). Ottawa: National Library of Canada = Bibliothèque nationale du Canada. OCLC 56752162.
  4. ^ Howard, Kaitlind C.; Dennis, Emily K.; Watt, David S.; Garneau-Tsodikova, Sylvie (2020-04-27). "A comprehensive overview of the medicinal chemistry of antifungal drugs: perspectives and promise". Chemical Society Reviews. 49 (8): 2426–2480. doi:10.1039/C9CS00556K. ISSN 1460-4744. PMID 32140691. S2CID 212567513.
  5. ^ a b c "Sylvie Garneau-Tsodikova On Women In STEM". BioTechniques. 2020-03-24. Retrieved 2021-04-17.
  6. ^ "Sylvie Garneau-Tsodikova | Faculty History Project". faculty-history.dc.umich.edu. Retrieved 2021-04-17.
  7. ^ "Sylvie Garneau-Tsodikova, PhD", University of Kentucky, College of Pharmacy. Retrieved May 16, 2020.
  8. ^ "RSC Medicinal Chemistry Desktop Seminar Series". www.rsc.org. Retrieved 2021-04-17.
This page was last edited on 18 April 2023, at 06:23
Basis of this page is in Wikipedia. Text is available under the CC BY-SA 3.0 Unported License. Non-text media are available under their specified licenses. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc. WIKI 2 is an independent company and has no affiliation with Wikimedia Foundation.
Contact WIKI 2
Introduction
Terms of Service
Privacy Policy